Previous 10 | Next 10 |
Boston Scientific press release ( NYSE: BSX ): Q2 Non-GAAP EPS of $0.44 beats by $0.02 . Revenue of $3.24B (+5.5% Y/Y) beats by $20M . MedSurg: 4.5 percent reported, 7.9 percent operational and 4.8 percent organic Cardiovascular: 6.0 percent reported, 10.8 ...
Boston Scientific Announces Results for Second Quarter 2022 PR Newswire MARLBOROUGH, Mass. , July 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.244 billion during the second quarter of 2022, growing 5.4 p...
Boston Scientific ( NYSE: BSX ) is scheduled to announce Q2 earnings results on Wednesday, July 27th, before market open. The consensus EPS Estimate is $0.42 (+5.0% Y/Y) and the consensus Revenue Estimate is $3.22B (+4.9% Y/Y). Over the last 2 years, BSX has beaten E...
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. From 1/2/2016 to date, investing in all 50 stocks, equally weighted, would have produced a total return of 84.7%, a...
Although the healthcare sector has largely resisted this year's downward pressure, it is likely to succumb as pressure increases. Healthcare stocks have a well-deserved reputation for cyclical defense, but they are more likely to underperform in "secular" bear markets. Healthcare ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Goldman Sachs is gauging the impact of a potential recession as Wall Street approaches 2Q earnings season. The market goes into the reporting period with a low bar of +6% EPS growth for the S&P 500 ( SP500 ) ( NYSEARCA: SPY ) for 2Q. For the year, Goldman is bel...
--News Direct-- By Maryam Mahdi Boston Scientific and IBM Research are collaborating to create an AI-based platform that provides doctors with personalized insights into patients’ experiences with chronic pain – measuring and analyzing those experiences in a way th...
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. From 1/2/2016 to date investing in all 50 stocks, equally weighted, would have produced a total return of 69.6%, an...
--News Direct-- Shae Wilson grew up in a military family, bouncing around from California to Japan, and then to North Carolina where her family finally settled and put down roots. Strong and nurturing, Shae dreamed of becoming a medical doctor. That ambition took a turn when family ...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...